Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.
Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents. The company was founded in 2012 and is headquartered in Shanghai, China.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 2, 2022 | Series B | ¥500M | 13 | — | — | Detail |
Jul 28, 2021 | Series A | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
West Shanghai Group | — | Series B |
Joy Time | — | Series B |
Jifeng Ventures | — | Series B |
ALAN AMC | — | Series B |
BeFor Capital | — | Series B |
Co-Stone Venture Capital | — | Series B |
CS Capital | — | Series B |
Furong Capital | — | Series B |
Gaorong Capital | — | Series B |
GOVTOR | — | Series B |